SignatureFD’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$203 Hold
34
– – ﹤0.01% 3471
2026
Q2
$151 Sell
34
-404
-92% -$1.72K ﹤0.01% 3430
2026
Q1
$1.91K Hold
438
– – ﹤0.01% 3067
2025
Q4
$2.21K Hold
438
– – ﹤0.01% 2939
2025
Q3
$1.52K Buy
438
+34
+8% +$128 ﹤0.01% 3010
2025
Q2
$1.37K Buy
404
+360
+818% +$1.2K ﹤0.01% 2953
2025
Q1
$176 Sell
44
-69
-61% -$358 ﹤0.01% 3249
2024
Q4
$733 Hold
113
– – ﹤0.01% 3083
2024
Q3
$626 Buy
+113
New +$641 ﹤0.01% 3065

Other funds holding CTKB

SignatureFD's CTKB Position: Q3 2026 in Review

SignatureFD held its Cytek Biosciences (CTKB) position steady in Q3 2026 at 34 shares worth $203. The position accounts for ﹤0.01% of the portfolio, ranked #3471.

SignatureFD first reported a position in CTKB in Q3 2024 and has held it in 9 quarters since. The position peaked at $2.21K in Q4 2025. 150 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.

  • SignatureFD held 34 shares of Cytek Biosciences worth $203 as of Q3 2026.
  • SignatureFD left its Cytek Biosciences share count unchanged in Q3 2026.
  • Cytek Biosciences made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #3471 holding.
  • SignatureFD first reported a position in Cytek Biosciences in Q3 2024 and has held it in 9 quarters since.
  • SignatureFD's Cytek Biosciences position peaked at $2.21K in Q4 2025.
  • 150 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.